From policy to progress: Government initiatives impacting India’s lifesciences real estate…
Vishal Goel, MD, RX Propellant
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ayushman Bharat
Industry lauds Union Budget’s focus on Women’s Health
Overall, the Union Budget 2024 reflects a forward-looking approach
OPPI commends the Government's approach towards the healthcare…
Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry
Most are optimistic about the future but accentuate the need for investments in technology and other strategic measures to ensure…
Will Budget 2020 be a salve or a sting for India Pharma Inc?
Will the sector get their shocks post-budget, via a revamped UCPMP, further pricing woes, etc?
The Road Less Travelled – What Lies Ahead for the Healthcare and Medical Devices Sector?
With Ayushman Bharat nearing its one-year anniversary, the Indian healthcare industry stands at cross-roads leading to untapped…
Will NDA-2’s first budget be any different for the pharma sector?
With actual fiscal outcomes for FY19 falling short of the revenue estimates put out in the interim budget, FM Sitharaman will have…